Oncternal Therapeutics Inc
(ONCT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6,697 | 37,142 | 90,765 | 116,737 | 20,051 |
| Marketable Securities | 27,558 | 26,582 | N/A | N/A | N/A |
| TOTAL | $36,059 | $67,290 | $92,853 | $118,003 | $20,787 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 670 | 1,361 | 732 | 806 | 957 |
| TOTAL | $670 | $1,361 | $732 | $806 | $957 |
| Total Assets | $36,729 | $68,651 | $93,585 | $118,809 | $21,744 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,148 | 2,917 | 1,959 | 1,143 | 871 |
| Accrued Expenses | 3,877 | 4,678 | 3,431 | 3,042 | 2,731 |
| TOTAL | $5,198 | $7,682 | $5,465 | $5,858 | $7,341 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | N/A | 1,633 | 3,640 |
| Other Non-Current Liabilities | 145 | 0 | 0 | 0 | 91 |
| TOTAL | $1,479 | $N/A | $N/A | $N/A | $91 |
| Total Liabilities | $6,677 | $7,682 | $5,465 | $5,858 | $7,432 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2,960 | 2,936 | 2,471 | 2,464 | 769 |
| Common Shares | 3 | 3 | 49 | 49 | 15 |
| Retained earnings | -197,779 | -158,300 | -114,130 | -82,797 | -65,572 |
| Other shareholders' equity | 3 | 9 | 0 | 0 | 0 |
| TOTAL | $30,052 | $60,969 | $88,120 | $112,951 | $14,312 |
| Total Liabilities And Equity | $36,729 | $68,651 | $93,585 | $118,809 | $21,744 |